Morphea secondary to interferon betai B injection: A case and review of the literature

Basit Öğe Kaydı
dc.contributor.authorÖzlü, Emin
dc.contributor.authorKaradağ, Ayse Serap
dc.contributor.authorAkdeniz, Necmettin
dc.contributor.authorUzuncakmak, Tuğba Kevser
dc.contributor.authorZemheri, Ebru
dc.contributor.authorÖzkanlı, Şeyma
dc.date.accessioned2025-05-10T15:24:20Z
dc.date.issued2019
dc.departmentİstanbul Medeniyet Üniversitesi
dc.description.abstractInterferon beta (IFNß) is a drug used successfully in the treatment of multiple sclerosis (MS). Although IFNß is a safe and well-tolerated drug, dermatological side effects are common. The most common dermatological adverse effect is a local reaction at the injection site. It may also cause inflammatory and immune-mediated dermatological side effects. However, morphea induced by IFNßlb injection is very rare. © 2019, Dermatology Online Journal. All rights reserved.
dc.identifier.issn1087-2108
dc.identifier.issue4
dc.identifier.pmid31046913
dc.identifier.scopus2-s2.0-85065577252
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://hdl.handle.net/20.500.14730/6710
dc.identifier.volume25
dc.indekslendigikaynakScopus
dc.indekslendigikaynakPubMed
dc.language.isoen
dc.publisherDermatology Online Journal
dc.relation.ispartofDermatology Online Journal
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzKA_Scopus_20250302
dc.subjectInterferon beta; Morphea; Side effects
dc.titleMorphea secondary to interferon betai B injection: A case and review of the literature
dc.typeArticle

Dosyalar

Orijinal paket

Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
6710
Boyut:
1.16 MB
Biçim:
Adobe Portable Document Format
İndir

Koleksiyon

Scopus İndeksli Yayınlar Koleksiyonu
PubMed İndeksli Yayın Koleksiyonu